Showing 1 - 1 results of 1 for search 'Estera Okon', query time: 0.01s Refine Results
  1. 1
    Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies

    Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies by Anna Wawruszak, Jarogniew Luszczki, Damian Bartuzi, Joanna Kalafut, Estera Okon, Arkadiusz Czerwonka, Andrzej Stepulak

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: